NDC00143-2125-22: CHLOROQUINE PHOSPHATE TABLETS.
The CHLOROQUINE PHOSPHATE TABLETS is a the manufacturer industrial component. Key specifications include primary_container_type: BOTTLE, therapeutic_equivalent: ARALEN BY SANOFI/WINTHROP PHARM., medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 25.000 TABLETS, active_medicament_medicinal_strength: 500.000 MILLIGRAMS CHLOROQUINE PHOSPHATE ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: CHLOROQUINE PHOSPHATE TABLETS USP 500MG 25S BT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-267-9662, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| primary_container_type | BOTTLE |
| therapeutic_equivalent | ARALEN BY SANOFI/WINTHROP PHARM. |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 25.000 TABLETS |
| active_medicament_medicinal_strength | 500.000 MILLIGRAMS CHLOROQUINE PHOSPHATE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | CHLOROQUINE PHOSPHATE TABLETS USP 500MG 25S BT |
| NSN | 6505-01-267-9662 |
| THERAPEUTIC EQUIVALENT | ARALEN BY SANOFI/WINTHROP PHARM. |
| PRIMARY CONTAINER CONTENT QUANTITY | 25.000 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CHLOROQUINE PHOSPHATE TABLETS USP 500MG 25S BT |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 500.000 MILLIGRAMS CHLOROQUINE PHOSPHATE ACTIVE INGREDIENT |